TAVR Once Again Non-Inferior to Surgery

ACC Conference Reporter

ACC.16 | CHICAGO — The latest trial in the PARTNER series of transcatheter aortic valve replacement (TAVR) trials affirms the technique's non-inferiority to surgery for patients with symptomatic aortic valve stenosis. Read More >>>

Keywords: ACC Annual Scientific Session


< Back to Listings